Brief: Bone Therapeutics Treats First Patients In Pivotal JTA-004 Phase III Study

Biosenic SA

18/05/2020 06:17

May 18 (Reuters) - BONE THERAPEUTICS SA  BOTHE.BR :
    * BONE THERAPEUTICS TREATS FIRST PATIENTS IN PIVOTAL JTA-004
PHASE
III KNEE OSTEOARTHRITIS STUDY
    * SEVERAL CLINICAL TRIAL SITES IN EUROPE ARE ALSO EXPECTED
TO
RESUME RECRUITMENT ACTIVITIES AS COVID-19 LOCKDOWN MEASURES ARE
GRADUALLY BEING LIFTED
    * EXPECTS TO OBTAIN APPROVAL IN REMAINING 2 COUNTRIES IN
COURSE OF
MONTH
    * DESPITE LOCKDOWNS BEING LIFTED INTERNATIONALLY, PATIENT
RECRUITMENT AND PROGRESS OF CLINICAL TRIAL COULD STILL BE
DELAYED WITH CHANGE IN EVOLUTION OF COVID-19 PANDEMIC

Source text for Eikon:  ID:nGNEMhrG8 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))